|
Daily Medical Update
Nonglomerular hematuria
Thursday, June 11, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Revue medicale suisse (2024) - Narrative Review
Key Findings
- Urinary tract neoplasia risk was reported at 5% in patients with non-glomerular microscopic hematuria.
- Risk-stratified evaluation can reduce unnecessary invasive testing versus blanket workup while still identifying patients who need prompt urologic assessment.
📋 Practice Implication: Use malignancy risk stratification early in nonglomerular microscopic hematuria so cystoscopy and imaging are targeted to patients most likely to benefit.
|
Journal of clinical laboratory analysis (2026) - Multicenter Diagnostic Study
Key Findings
- The UPC index achieved an AUC of 0.857 for distinguishing glomerular disease from extrarenal disease versus 0.779 for URD, 0.746 for ACR, and 0.648 for PCR.
- At a cutoff of 3.99, the UPC index identified glomerular disease with 86.7% sensitivity and 73.1% specificity.
📋 Practice Implication: When dipstick hematuria is accompanied by proteinuria or kidney dysfunction, a UPC-style composite index could help redirect evaluation away from a purely urologic workup.
|
Glomerular diseases (2025) - Biopsy-Correlated Diagnostic Cohort
Key Findings
- Urinary acanthocytes alone diagnosed glomerulonephritis with 68% sensitivity, 86% specificity, 78% positive predictive value, and 79% negative predictive value.
- Combining urinary acanthocytes with red blood cell casts increased sensitivity to 75% and negative predictive value to 83%, and at least one marker was present in 92% of crescentic or necrotizing glomerulonephritis cases.
📋 Practice Implication: If acanthocytes or red blood cell casts are present, clinicians should lower the threshold for nephrology referral and avoid assuming a nonglomerular source.
|
Archives of pathology & laboratory medicine (2026) - Retrospective Diagnostic Study
Key Findings
- %dRBC identified glomerular disease with an AUROC of 0.766, and a 17% cutoff yielded 32.2% sensitivity with 95.8% specificity.
- Raising the cutoff to 28% reduced sensitivity to 21.1% but increased specificity to 97.2%, supporting a high-rule-in signal when dysmorphic cells are abundant.
📋 Practice Implication: A strongly positive automated dysmorphic RBC result can justify prioritizing renal evaluation before expanding a full nonglomerular hematuria workup.
|
BMC nephrology (2026) - Multicenter Diagnostic Study
Key Findings
- A combined dysmorphic RBC proportion above 26% differentiated glomerular from non-glomerular hematuria with 92.2% sensitivity, 81.7% specificity, and an AUC of 0.907.
- The random forest model improved classification further, reaching an AUC of 0.960 with 96.6% sensitivity and 85.9% specificity in validation.
📋 Practice Implication: Laboratories using advanced urine analyzers may be able to standardize triage of hematuria origin and reserve manual review for indeterminate cases.
|
|
💡
Summary
Recent evidence on nonglomerular hematuria remains dominated by studies that help separate glomerular from nonglomerular bleeding and by risk-stratification guidance for malignancy evaluation. Only three first-pass candidates met the clinical-significance threshold of 7 or higher, so two lower-scoring diagnostic studies were included to complete the set; this suggests the recent research pool was sparse for strictly nonglomerular hematuria terms and that search terms may need to be broadened.
|
|